Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

NCT01471782

Conditions
Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • Children's Hospital Denver Aurora, Colorado, United States
  • Children's Healthcare of Atlanta at Egleston Atlanta, Georgia, United States
  • Washington University St Louis, Missouri, United States
  • Memorial Sloan Kettering New York, United States
View all 30 locations
View Trial Details
Completed

EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT01040832

Conditions
Disease Attributes, Head and Neck Neoplasms, Neoplasms, +5 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Kentucky, Markey Cancer Center Lexington, Kentucky, United States
  • MGH Massachusetts General Hospital Boston, Massachusetts, United States
  • Montefiore Medical Center Oncology The Bronx, New York, United States
View all 35 locations
View Trial Details
Completed

Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment

NCT02341781

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Mayo Clinic Scottsdale Phoenix, Arizona, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • University of Miami and Sylvester Comprehensive Cancer Miami, Florida, United States
  • University of Michigan Comprehensive Cancer Center Division of Hematology Oncology Ann Arbor, Michigan, United States
View all 14 locations
View Trial Details
Completed

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

NCT01520922

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
Locations
  • Novartis Investigative Site Tuscon, Arizona, United States
  • Novartis Investigative Site Aurora, Colorado, United States
  • Novartis Investigative Site Fort Myers, Florida, United States
  • Novartis Investigative Site St. Petersburg, Florida, United States
View all 33 locations
View Trial Details
Completed

Long-Term Safety and Efficacy Study of Peginterferon Beta-1a

NCT01332019

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Research Site Atlanta, Georgia, United States
  • Research Site Lexington, Kentucky, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Raleigh, North Carolina, United States
View all 151 locations
View Trial Details

Related conditions